The introduction of the 505(b)(2) application pathway by the USFDA has turned out to be a game-changer for pharma companies. Not only has it led to faster drug approvals compared…
Personalised medicines – where do we stand today?
The medical science and healthcare systems are evolving daily, thanks to the staggering progress in technology and research. One breakthrough…
Towards a sustainable future
April 8, 2021
Orphan Drugs – Reviving the Pharma and the Patients
March 4, 2021
Because patients come first
February 22, 2021
Current trends in oral solid dosage forms
February 9, 2021
Fighting Counterfeit Drugs
January 27, 2021
The Need for Child-resistant Packaging of Tobacco Products
January 22, 2021